Eris Lifesciences/Natco Pharma partner on semaglutide for India
Natco Pharma has received regulatory approval in India, paving the way for a launch in March 2026
Natco Pharma has received regulatory approval in India, paving the way for a launch in March 2026
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
